Navamedic ASA: Notification of major shareholding and mandatory notification of trade

The shares have been acquired by institutional and private investors, of which several are international investors with a particular interest for pharma. The shares have been acquired by institutional and private investors, of which several are international investors with a particular interest for pharma. "Navamedic has had an extraordinary development over the past few years. In 2023, revenues passed theNOK 500 millionmark, nearly three times revenues in 2019. It has secured rights to...

The shares have been acquired by institutional and private investors, of which several are international investors with a particular interest for pharma.

"Navamedic has had an extraordinary development over the past few years. In 2023, revenues passed the NOK 500 million mark, nearly three times revenues in 2019. It has secured rights to a number of attractive products for sale in the Nordic region and Europe and is also looking at opportunities elsewhere in the world," Bakken continued.

IRIC is controlled by Narve Reiten and a close associate to the chairman Terje Bakken and board member Narve Reiten in Navamedic ASA ("Navamedic"). The number of shares sold today was 2,965,618 shares, equaling approximately 17.1 percent of the share capital and votes in Navamedic, reducing IRIC's holding of shares and votes to zero. IRIC has no other rights to shares in Navamedic.

This disclosure is made pursuant to article 19 of the EU Market Abuse Regulation and sections 4-2 and  5-12 of the Norwegian Securities Trading Act.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/navamedic-asa/r/navamedic-asa--notification-of-major-shareholding-and-mandatory-notification-of-trade,c3944854

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/navamedic-asa-notification-of-major-shareholding-and-mandatory-notification-of-trade-302087377.html